Skip to main content

MAIA Biotechnology, Inc.

MAIA
Exchange
NYSE
Industry
Pharmaceutical Preparations
SEC CIK
0001878313

In the last 90 days, MAIA Biotechnology, Inc. insiders filed 7 open-market purchases and 0 sales; 43 institutions reported holding it in 13F filings for Q3 2026, worth $14.2M in total; no superinvestor holds it.

Holders of 5% or more of MAIA

Holders whose latest Schedule 13D or 13G filing reports 5% or more of MAIA Biotechnology, Inc., largest stake first. The change is against the holder's previous filing.

Holders of 5% or more of MAIA
HolderLatest formStakeChangeFirst filedLatest filingFiling
FGMK Business Holdings, LLC13G9.99%2.89M sharesNewMar 3, 20251 filingMar 3, 2025SEC
Vitoc Vlad13D/A9.66%3.85M shares–Feb 14, 20233 filingsDec 4, 2025SEC

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

12 Schedule 13D and 13G filings on MAIA Biotechnology, Inc., newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on MAIA
Filed (ET)FilerFormStakeChangeEvent dateFiling
Aug 14, 202610:47 AM ETSolas Capital Management, LLCand 1 other13G/A4.90%3.03M shares−2.20 ppfrom 7.10%Below 5%Jun 30, 2026SEC
May 15, 202611:06 AM ETSolas Capital Management, LLCand 1 other13G7.10%4.30M sharesNewMar 31, 2026SEC
Dec 4, 20254:05 PM ETVitoc Vlad13D/A9.66%3.85M shares–Nov 21, 2025SEC
Mar 3, 20255:28 PM ETFGMK Business Holdings, LLCand 1 other13G9.99%2.89M sharesNewSep 14, 2024SEC
Feb 14, 20255:27 PM ETGryaznov Sergei13G/A4.08%1.14M shares–Below 5%Dec 31, 2023SEC
Oct 25, 2024Smith Stan13D/AOld format–––SEC
Oct 25, 2024Louie Ngar Yee13DOld format–––SEC
Oct 25, 2024Vitoc Vlad13DOld format–––SEC
Feb 14, 2023Louie Ngar Yee13GOld format–New–SEC
Feb 14, 2023Gryaznov Sergei13GOld format–New–SEC
Feb 14, 2023Vitoc Vlad13GOld format–New–SEC
Aug 10, 2022Smith Stan13DOld format–New–SEC

Form 144: proposed insider sales

1 notice from officers, directors and other affiliates planning to sell MAIA Biotechnology, Inc. shares, newest first.

Form 144 notices for MAIA
Filed (ET)SellerShares to sellMarket valuePlanned saleBrokerFiling
Jan 19, 20249:00 PM ETObrocea MihailFormer director26.1K$33.4KJan 19, 2024Fidelity Brokerage Services LLCSEC